Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Yet another weekend to ponder..different this time

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Oct 22, 2023 10:26am

106 Views

Post# 35695225

RE:RE:RE:RE:RE:Yet another weekend to ponder..different this time

Anyone unhappy with their investment is welcome to sell up and go away. Outside of sport what other endeavor is there where you pick your side, invest your money then complain over and over when it doesn't go your way.

This company is doing their job to get this drug to market. Not as quick as we'd all like and communication has been abysmal but the inevitably of Pela getting to market is undeniable.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market